Holen Sie sich die Stockscreener-App
702.21
1.40%
-11.35
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$713.56
Offen:
$709.83
24-Stunden-Volumen:
191.01K
Relative Volume:
0.42
Marktkapitalisierung:
$56.21B
Einnahmen:
$4.17B
Nettoeinkommen (Verlust:
$1.03B
KGV:
55.67
EPS:
12.6148
Netto-Cashflow:
$940.22M
1W Leistung:
-1.42%
1M Leistung:
+11.09%
6M Leistung:
+38.19%
1J Leistung:
+63.69%
1-Tages-Spanne:
$702.00
$715.89
1-Wochen-Bereich:
$699.85
$719.25
52-Wochen-Spanne:
$356.14
$735.00
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Vergleichen Sie IDXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
702.62 | 56.98B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
590.28 | 220.92B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
223.93 | 154.97B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
149.34 | 42.96B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
225.32 | 37.62B | 15.90B | 1.28B | 2.21B | 7.2842 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Why IDEXX Laboratories Inc. (IX1) stock stays undervaluedWeekly Profit Analysis & Reliable Volume Spike Trade Alerts - newser.com
Why retail investors favor IDEXX Laboratories Inc. stock2025 Key Lessons & Weekly High Potential Stock Alerts - newser.com
Does IDEXX Laboratories Inc. fit your quant trading modelJuly 2025 Breakouts & Safe Entry Point Identification - newser.com
Insider Move: Nimrata Hunt Exercises Options, Realizing $4.10M At IDEXX Laboratories - Benzinga
Idexx Laboratories Insider Sold Shares Worth $6,629,014, According to a Recent SEC Filing - MarketScreener
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$6.63 Million in Common Stock - 富途牛牛
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $775 - 富途牛牛
Here’s Why IDEXX Laboratories (IDXX) Surged in Q3 - Insider Monkey
Quantitative breakdown of IDEXX Laboratories Inc. recent moveJuly 2025 Trade Ideas & Fast Gaining Stock Reports - newser.com
Piper Sandler Adjusts Price Target on IDEXX Laboratories to $775 From $700 - MarketScreener
Is IDEXX Laboratories Inc. stock supported by strong cash flowsJuly 2025 Intraday Action & Expert Verified Movement Alerts - newser.com
Trend analysis for IDEXX Laboratories Inc. this weekFed Meeting & Capital Protection Trading Alerts - newser.com
Building trade automation scripts for IDEXX Laboratories Inc.Breakout Watch & AI Based Buy/Sell Signal Reports - newser.com
Will IDEXX Laboratories Inc. stock recover after recent dropPortfolio Return Report & Weekly Breakout Stock Alerts - newser.com
What machine learning models say about IDEXX Laboratories Inc.2025 Trade Ideas & Real-Time Stock Price Movement Reports - newser.com
IDEXX Laboratories Hits Day High with 14.84% Surge in Stock Price - Markets Mojo
What analyst consensus implies for IDEXX Laboratories Inc. (IX1) stockQuarterly Risk Review & Weekly Top Gainers Alerts - newser.com
Why IDEXX Laboratories (IDXX) Is Up 13.6% After Strong Q3 Results and Raised 2025 Guidance - Yahoo Finance
Earnings Beat: IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Will earnings trigger a reversal in IDEXX Laboratories Inc.2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Agree To Buy Idexx Laboratories At $600, Earn 5.3% Annualized Using Options - Nasdaq
Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX) - Insider Monkey
Is IDEXX Laboratories Inc. stock a safe buy before earningsJuly 2025 Earnings & Technical Buy Zone Confirmations - newser.com
Assessing IDEXX Laboratories After a 76% Rally and Surging Pet Healthcare Demand - Sahm
IDEXX Laboratories Reports Strong Q3 Earnings and Raises Guidance - The Globe and Mail
Is IDEXX Laboratories Inc. stock ready for a breakoutTrade Ideas & Daily Stock Momentum Reports - newser.com
IDEXX Laboratories Hits New 52-Week High of $734.64, Up 42.24% - Markets Mojo
IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $775.00 - MarketBeat
Blue Barn Wealth LLC Takes $225,000 Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Jacobson & Schmitt Advisors LLC Grows Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Bridgewater Advisors Inc. Takes Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
415 Shares in IDEXX Laboratories, Inc. $IDXX Acquired by Fullcircle Wealth LLC - MarketBeat
Bank of Montreal Can Boosts Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Arkadios Wealth Advisors Acquires New Shares in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX outlines 9.6%–10.3% revenue growth outlook for 2025 amid robust CAG Diagnostics expansion - MSN
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Idexx Laboratories Inc-Aktie (IDXX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hunt Nimrata | Executive Vice President |
Nov 07 '25 |
Sale |
703.34 |
9,425 |
6,629,014 |
21,149 |
1.13%
2.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):